Table 1.
Demographic | Included Sample | Non-Participants at Adulthood Follow-Up | Non-Participants in Childhood Neuropsychological Testing |
---|---|---|---|
N | 24 | 8 | 20 |
Gender (% male) | 22 (92%) | 8 (100%) | 12 (60%) |
Baseline Childhood Assessment | |||
Age | 11.5 +/- 2.4 | 10.9 +/- 1.9 | 12.7 +/- 1.4 |
OCD Severity | 11.4 +/-8.9 | 15.4 +/- 11.6 | 11.9 +/- 7.4 |
Worst-Ever OCD Severity | 27.9 +/- 7.5 | 24.9 +/- 8.9 | 23.6 +/- 6.7 |
Tics | 18 (75%) | 5 (63%) | 8 (40%) |
ADHD | 10 (42%) | 3 (37%) | 8 (40%) |
Primary Hoarding | 5 (21%) | 1 (13%) | 5 (25%) |
SRI | 22 (92%) | 6 (75%) | 18 (90%) |
Neuroleptics | 15 (63%) | 5 (63%) | 8 (40%) |
Alpha-2 Agonists | 10 (42%) | 2 (25%) | 3 (15%) |
Psychostimulants | 10 (42%) | 1 (13%) | 5 (25%) |
Adulthood Follow-Up Assessment | |||
Age | 19.0 +/- 1.9 | 23.5 +/- 2.5 | |
OCD Severity | 9.7 +/- 9.8 | 10.6 +/- 7.2 | |
SRI | 16 (67%) | 10 (50%) | |
Neuroleptics | 4 (17%) | 3 (15%) | |
Alpha-2 Agonists | 2 (8%) | 0 | |
Psychostimulants | 1 (4%) | 1 (5%) |
Seventy-five percent of eligible participants participated in adulthood follow-up interview. Participants and non-participants in adulthood follow-up assessment did not differ significantly in any demographic characteristics at baseline. Children who did not participate in neuropsychological testing at childhood baseline had a lower rate of comorbid tic disorders than those children who participated (χ2=5.2, df=1, p=0.02).